• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP

CYNATA THERAPEUTICS LIMITED

5.00% ! 19.0¢
Market Cap $45.11M  !
Healthcare Biotechnology
Add to My Watchlist

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CYP
"Good vibes Here Dudes".....
2 3
09/09/25 153 52K
09/09/25 Last post  Pledge Comments Created with Sketch.  153  Views Created with Sketch.  52K 
CYP
CYP Price Target post MSB FDA approval.
5 6 7
06/09/25 392 117K
06/09/25 Last post  Pledge Comments Created with Sketch.  392  Views Created with Sketch.  117K 
CYP
Ann: Corporate Governance Statement 		30/08/25 1 265
30/08/25 Last post  Pledge Comments Created with Sketch.  1  Views Created with Sketch.  265 
CYP
Ann: Appendix 4G 		28/08/25 0 144
28/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  144 
CYP
Ann: Appendix 4E & Annual Report 		28/08/25 0 217
28/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  217 
CYP
Ann: Cynata to present at Bioshares Biotech Summit 		27/08/25 4 1.1K
27/08/25 Last post  Pledge Comments Created with Sketch.  4  Views Created with Sketch.  1.1K 
CYP
Ann: At-the-Market Subscription Agreement 		27/08/25 39 5.0K
27/08/25 Last post  bedger Comments Created with Sketch.  39  Views Created with Sketch.  5.0K 
CYP
Ann: Change in substantial holding 		26/08/25 0 236
26/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  236 

See All Discussions arrow Created with Sketch.

Timeline

Appendix 4G
28 Aug 18:24
 
Corporate Governance Statement
28 Aug 18:23
 
Appendix 4E & Annual Report
28 Aug 18:23
 
Change in substantial holding
26 Aug 18:23
 
Cleansing Notice
22 Aug 09:18
 
Application for quotation of securities - CYP
22 Aug 09:18
 
View More arrow Created with Sketch.

Featured News

NEWS Stay ahead - view the latest ASX market news
right-arrow Created with Sketch.
NEWS Rubix advances proposed acquisition of prospective Bauxite Projects in Africa
right-arrow Created with Sketch.
NEWS Vulcan signs first major Phase One contract with NESI
right-arrow Created with Sketch.
MEM Memphasys secures transformational A$325K initial order with exclusive Middle East partnership
right-arrow Created with Sketch.
NEWS Final toll milling completed at Jeffreys Find Gold Mine
right-arrow Created with Sketch.
NEWS Marquee confirms high-grade antimony ahead of maiden JORC resource
right-arrow Created with Sketch.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
19.0¢ 		Change
-0.010(5.00%) 		Mkt cap ! $45.11M
Open High Low Value Volume
20.0¢ 20.0¢ 19.0¢ $74.40K 381.5K

Buyers (Bids)

No. Vol. Price($)
4 97201 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 20378 1
View Market Depth
Last trade - 16.10pm 09/09/2025 (20 minute delay) ?
CYP (ASX) Chart

Top Stories

Nanocap Livium pops +30% on purchase of REE extraction technology from Melb Uni

Livium has become one of the nanocaps juicing hard, with shares up nearly +30% as the company inks a deal alongside Melbourne University.
It's a penny stock buyer's market. Adelong Gold jumps +20% as Nova Mins buys in Adelong Gold, a nanocap and pennystock, jumped +20% in mid-arvo trades after Nova Minerals, also listed on the Nasdaq, bought a 9.4% stake.
Talga back to 50cps on news it's cracked US battery market – with metals recycling shine Shareholders in sometimes troubled graphite player Talga Group have rewarded the company's acumen to move into the U.S. battery anode market.
Market Close: 4DX Medical finally pulls back; war makes ESG investing cool again Good Afternoon and welcome to HotCopper’s Market Close for Tuesday 9th of September, I’m Jon Davidson. The ASX200 retreated back to the 8,700s intraday as Wall Street finished flattish green overnight leaving little to imagine in terms of bullish sentiment; as of 3...
Listen: HotCopper Wire Podcast 023 – Glowing gold, shining silver, and... wheat collusion? In this HotCopper Wire episode, we look at surging gold and silver as well as Trump's appeals court clash, and a wheat futures conspiracy.

Featured News

NEWS Marquee confirms high-grade antimony ahead of maiden JORC resource
right-arrow Created with Sketch.
BML Boab Metals secures path to full ownership of Sorby Hills Project
right-arrow Created with Sketch.
NEWS Arrowsmith North Silica Sand Project granted works approval
right-arrow Created with Sketch.
AII Why Almonty Industries is THE tungsten mining stock to watch
right-arrow Created with Sketch.
NEWS HotCopper Highlights: 4DS Memory's strategic review flags strategic review & more
right-arrow Created with Sketch.
NEWS Vulcan signs first major Phase One contract with NESI
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.